Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  recombinant human endostatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-14 of 14 for your search:
Start Over
Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: ECF/endo-MGC, NCT00595972
Neoadjuvant Endostatin and Chemotherapy for Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: Endostar B-01, XOBCR01, NCT00604435
Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: XYL014, NCT00708812
Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: ENDOCX, NCT00842491
Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: SIM-69, NCT00912392
A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 12 to 60
Sponsor: Pharmaceutical / Industry
Protocol IDs: SIM-65, NCT01002092
Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: DP-EN-RT, NCT01218594
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: SIM-90, NCT01327235
Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography
Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: XIANSHENG, NCT01347424
Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ZhejaingCH-npc-02, NCT01612286
Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 to 30
Sponsor: Other
Protocol IDs: Tian-drug-neuro001, ChiCTR-ONRC-14004210, NCT02104323
Endostatin in Treating Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02314, MDA-ID-99201, NCI-T99-0087, CDR0000067471, T99-0087, NCT00004229
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000067532, P30CA014520, WCCC-CO-99910, NCI-T99-0055, T99-0055, NCT00004872
A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: SIM-93, NCT01531790
Start Over